PubMed:26572140 JSONTXT

{"project":"GlyCosmos600-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":422,"end":431},"obj":"https://glytoucan.org/Structures/Glycans/G71832QJ"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos600-CLO","denotations":[{"id":"T1","span":{"begin":460,"end":463},"obj":"http://purl.obolibrary.org/obo/CLO_0007169"},{"id":"T2","span":{"begin":511,"end":514},"obj":"http://purl.obolibrary.org/obo/CLO_0007169"},{"id":"T3","span":{"begin":617,"end":620},"obj":"http://purl.obolibrary.org/obo/CLO_0007169"},{"id":"T4","span":{"begin":686,"end":689},"obj":"http://purl.obolibrary.org/obo/CLO_0007169"},{"id":"T5","span":{"begin":739,"end":742},"obj":"http://purl.obolibrary.org/obo/CLO_0007169"},{"id":"T6","span":{"begin":823,"end":826},"obj":"http://purl.obolibrary.org/obo/CLO_0007169"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":422,"end":431},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71832QJ"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":422,"end":431},"obj":"https://glytoucan.org/Structures/Glycans/G71832QJ"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T2","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"T3","span":{"begin":60,"end":65},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T4","span":{"begin":60,"end":65},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"T5","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T6","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos600-FMA","denotations":[{"id":"T1","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T2","span":{"begin":60,"end":65},"obj":"Body_part"},{"id":"T3","span":{"begin":105,"end":121},"obj":"Body_part"},{"id":"T4","span":{"begin":151,"end":156},"obj":"Body_part"},{"id":"T5","span":{"begin":163,"end":179},"obj":"Body_part"},{"id":"T6","span":{"begin":1040,"end":1048},"obj":"Body_part"},{"id":"T7","span":{"begin":1121,"end":1137},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma82742"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma82742"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma82742"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"NGLY1-deficiency","denotations":[{"id":"PD-NGLY1-deficiency-B_T1","span":{"begin":569,"end":575},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T2","span":{"begin":641,"end":647},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T3","span":{"begin":710,"end":716},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T4","span":{"begin":762,"end":768},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T5","span":{"begin":833,"end":839},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T6","span":{"begin":896,"end":902},"obj":"chem:24139"}],"namespaces":[{"prefix":"hgnc","uri":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:"},{"prefix":"omim","uri":"https://www.omim.org/entry/"},{"prefix":"chem","uri":"https://pubchem.ncbi.nlm.nih.gov/compound/"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":151,"end":344},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":345,"end":954},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":955,"end":1068},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":1069,"end":1180},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"T2","span":{"begin":151,"end":344},"obj":"Sentence"},{"id":"T3","span":{"begin":345,"end":954},"obj":"Sentence"},{"id":"T4","span":{"begin":955,"end":1068},"obj":"Sentence"},{"id":"T5","span":{"begin":1069,"end":1180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos600-MAT","denotations":[{"id":"PD-MAT-B_T1","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"PD-MAT-B_T2","span":{"begin":60,"end":65},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"PD-MAT-B_T3","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"PD-MAT-B_T4","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"PD-MAT-B_T5","span":{"begin":60,"end":65},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"PD-MAT-B_T6","span":{"begin":151,"end":156},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos600-GlycoGenes","denotations":[{"id":"PD-GlycoGenes-B_T1","span":{"begin":50,"end":53},"obj":"GGDB:A(ABO)"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"pubmed-enju-pas","denotations":[{"id":"EnjuParser_T0","span":{"begin":0,"end":2},"obj":"DT"},{"id":"EnjuParser_T1","span":{"begin":3,"end":14},"obj":"JJ"},{"id":"EnjuParser_T2","span":{"begin":15,"end":24},"obj":"NN"},{"id":"EnjuParser_T3","span":{"begin":25,"end":27},"obj":"IN"},{"id":"EnjuParser_T4","span":{"begin":28,"end":39},"obj":"NN"},{"id":"EnjuParser_T5","span":{"begin":40,"end":48},"obj":"NNS"},{"id":"EnjuParser_T6","span":{"begin":48,"end":49},"obj":"-COMMA-"},{"id":"EnjuParser_T7","span":{"begin":50,"end":53},"obj":"NN"},{"id":"EnjuParser_T8","span":{"begin":54,"end":65},"obj":"NN"},{"id":"EnjuParser_T9","span":{"begin":66,"end":71},"obj":"NN"},{"id":"EnjuParser_T10","span":{"begin":72,"end":76},"obj":"NN"},{"id":"EnjuParser_T11","span":{"begin":77,"end":79},"obj":"CD"},{"id":"EnjuParser_T12","span":{"begin":80,"end":88},"obj":"NNS"},{"id":"EnjuParser_T13","span":{"begin":89,"end":92},"obj":"CC"},{"id":"EnjuParser_T14","span":{"begin":93,"end":104},"obj":"NN"},{"id":"EnjuParser_T15","span":{"begin":105,"end":121},"obj":"NNS"},{"id":"EnjuParser_T16","span":{"begin":122,"end":126},"obj":"IN"},{"id":"EnjuParser_T17","span":{"begin":127,"end":132},"obj":"NN"},{"id":"EnjuParser_T18","span":{"begin":133,"end":137},"obj":"NN"},{"id":"EnjuParser_T19","span":{"begin":138,"end":149},"obj":"NNS"},{"id":"EnjuParser_T20","span":{"begin":151,"end":156},"obj":"NN"},{"id":"EnjuParser_T21","span":{"begin":157,"end":162},"obj":"NN"},{"id":"EnjuParser_T22","span":{"begin":163,"end":179},"obj":"NNS"},{"id":"EnjuParser_T23","span":{"begin":180,"end":183},"obj":"VBP"},{"id":"EnjuParser_T24","span":{"begin":184,"end":187},"obj":"CD"},{"id":"EnjuParser_T25","span":{"begin":188,"end":190},"obj":"IN"},{"id":"EnjuParser_T26","span":{"begin":191,"end":194},"obj":"DT"},{"id":"EnjuParser_T27","span":{"begin":195,"end":199},"obj":"RBS"},{"id":"EnjuParser_T28","span":{"begin":200,"end":210},"obj":"RB"},{"id":"EnjuParser_T29","span":{"begin":211,"end":220},"obj":"JJ"},{"id":"EnjuParser_T30","span":{"begin":221,"end":228},"obj":"NN"},{"id":"EnjuParser_T31","span":{"begin":229,"end":237},"obj":"NNS"},{"id":"EnjuParser_T32","span":{"begin":238,"end":241},"obj":"CC"},{"id":"EnjuParser_T33","span":{"begin":242,"end":246},"obj":"PRP"},{"id":"EnjuParser_T34","span":{"begin":247,"end":250},"obj":"MD"},{"id":"EnjuParser_T35","span":{"begin":251,"end":255},"obj":"RB"},{"id":"EnjuParser_T36","span":{"begin":256,"end":259},"obj":"VB"},{"id":"EnjuParser_T37","span":{"begin":260,"end":262},"obj":"IN"},{"id":"EnjuParser_T38","span":{"begin":263,"end":272},"obj":"JJ"},{"id":"EnjuParser_T39","span":{"begin":273,"end":280},"obj":"NNS"},{"id":"EnjuParser_T40","span":{"begin":281,"end":284},"obj":"IN"},{"id":"EnjuParser_T41","span":{"begin":285,"end":294},"obj":"JJ"},{"id":"EnjuParser_T42","span":{"begin":295,"end":301},"obj":"NNS"},{"id":"EnjuParser_T43","span":{"begin":302,"end":306},"obj":"IN"},{"id":"EnjuParser_T44","span":{"begin":307,"end":318},"obj":"NNP"},{"id":"EnjuParser_T45","span":{"begin":319,"end":323},"obj":"NNP"},{"id":"EnjuParser_T46","span":{"begin":324,"end":327},"obj":"CC"},{"id":"EnjuParser_T47","span":{"begin":328,"end":334},"obj":"NNP"},{"id":"EnjuParser_T48","span":{"begin":335,"end":343},"obj":"NNS"},{"id":"EnjuParser_T50","span":{"begin":955,"end":959},"obj":"DT"},{"id":"EnjuParser_T51","span":{"begin":960,"end":966},"obj":"NN"},{"id":"EnjuParser_T52","span":{"begin":967,"end":970},"obj":"VBD"},{"id":"EnjuParser_T53","span":{"begin":971,"end":977},"obj":"VBN"},{"id":"EnjuParser_T54","span":{"begin":978,"end":980},"obj":"RB"},{"id":"EnjuParser_T55","span":{"begin":981,"end":983},"obj":"IN"},{"id":"EnjuParser_T56","span":{"begin":984,"end":986},"obj":"TO"},{"id":"EnjuParser_T57","span":{"begin":987,"end":997},"obj":"VB"},{"id":"EnjuParser_T58","span":{"begin":998,"end":1001},"obj":"DT"},{"id":"EnjuParser_T59","span":{"begin":1002,"end":1008},"obj":"JJ"},{"id":"EnjuParser_T60","span":{"begin":1009,"end":1020},"obj":"NN"},{"id":"EnjuParser_T61","span":{"begin":1021,"end":1023},"obj":"IN"},{"id":"EnjuParser_T62","span":{"begin":1024,"end":1027},"obj":"DT"},{"id":"EnjuParser_T63","span":{"begin":1028,"end":1036},"obj":"NNS"},{"id":"EnjuParser_T64","span":{"begin":1037,"end":1039},"obj":"TO"},{"id":"EnjuParser_T65","span":{"begin":1040,"end":1048},"obj":"NNS"},{"id":"EnjuParser_T66","span":{"begin":1049,"end":1051},"obj":"CC"},{"id":"EnjuParser_T67","span":{"begin":1052,"end":1057},"obj":"JJ"},{"id":"EnjuParser_T68","span":{"begin":1058,"end":1067},"obj":"NNS"},{"id":"EnjuParser_T69","span":{"begin":1069,"end":1071},"obj":"PRP"},{"id":"EnjuParser_T70","span":{"begin":1072,"end":1076},"obj":"RB"},{"id":"EnjuParser_T71","span":{"begin":1077,"end":1085},"obj":"VBD"},{"id":"EnjuParser_T72","span":{"begin":1086,"end":1089},"obj":"DT"},{"id":"EnjuParser_T73","span":{"begin":1090,"end":1100},"obj":"NNS"},{"id":"EnjuParser_T74","span":{"begin":1101,"end":1103},"obj":"IN"},{"id":"EnjuParser_T75","span":{"begin":1104,"end":1108},"obj":"DT"},{"id":"EnjuParser_T76","span":{"begin":1109,"end":1120},"obj":"VBN"},{"id":"EnjuParser_T77","span":{"begin":1121,"end":1137},"obj":"NNS"},{"id":"EnjuParser_T78","span":{"begin":1138,"end":1145},"obj":"IN"},{"id":"EnjuParser_T79","span":{"begin":1146,"end":1148},"obj":"NNP"},{"id":"EnjuParser_T80","span":{"begin":1149,"end":1152},"obj":"NNP"},{"id":"EnjuParser_T81","span":{"begin":1153,"end":1156},"obj":"NN"},{"id":"EnjuParser_T82","span":{"begin":1157,"end":1163},"obj":"NN"},{"id":"EnjuParser_T83","span":{"begin":1164,"end":1168},"obj":"IN"},{"id":"EnjuParser_T84","span":{"begin":1169,"end":1171},"obj":"NNP"},{"id":"EnjuParser_T85","span":{"begin":1172,"end":1179},"obj":"NN"}],"relations":[{"id":"EnjuParser_R0","pred":"arg1Of","subj":"EnjuParser_T2","obj":"EnjuParser_T0"},{"id":"EnjuParser_R1","pred":"arg1Of","subj":"EnjuParser_T2","obj":"EnjuParser_T1"},{"id":"EnjuParser_R2","pred":"arg1Of","subj":"EnjuParser_T2","obj":"EnjuParser_T3"},{"id":"EnjuParser_R3","pred":"arg2Of","subj":"EnjuParser_T5","obj":"EnjuParser_T3"},{"id":"EnjuParser_R4","pred":"arg1Of","subj":"EnjuParser_T5","obj":"EnjuParser_T4"},{"id":"EnjuParser_R5","pred":"arg1Of","subj":"EnjuParser_T2","obj":"EnjuParser_T6"},{"id":"EnjuParser_R6","pred":"arg2Of","subj":"EnjuParser_T13","obj":"EnjuParser_T6"},{"id":"EnjuParser_R7","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T7"},{"id":"EnjuParser_R8","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T8"},{"id":"EnjuParser_R9","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T9"},{"id":"EnjuParser_R10","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T10"},{"id":"EnjuParser_R11","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T11"},{"id":"EnjuParser_R12","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T13"},{"id":"EnjuParser_R13","pred":"arg2Of","subj":"EnjuParser_T15","obj":"EnjuParser_T13"},{"id":"EnjuParser_R14","pred":"arg1Of","subj":"EnjuParser_T15","obj":"EnjuParser_T14"},{"id":"EnjuParser_R15","pred":"arg1Of","subj":"EnjuParser_T15","obj":"EnjuParser_T16"},{"id":"EnjuParser_R16","pred":"arg2Of","subj":"EnjuParser_T19","obj":"EnjuParser_T16"},{"id":"EnjuParser_R17","pred":"arg1Of","subj":"EnjuParser_T19","obj":"EnjuParser_T17"},{"id":"EnjuParser_R18","pred":"arg1Of","subj":"EnjuParser_T19","obj":"EnjuParser_T18"},{"id":"EnjuParser_R19","pred":"arg1Of","subj":"EnjuParser_T22","obj":"EnjuParser_T20"},{"id":"EnjuParser_R20","pred":"arg1Of","subj":"EnjuParser_T22","obj":"EnjuParser_T21"},{"id":"EnjuParser_R21","pred":"arg1Of","subj":"EnjuParser_T22","obj":"EnjuParser_T23"},{"id":"EnjuParser_R22","pred":"arg2Of","subj":"EnjuParser_T24","obj":"EnjuParser_T23"},{"id":"EnjuParser_R23","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T25"},{"id":"EnjuParser_R24","pred":"arg2Of","subj":"EnjuParser_T31","obj":"EnjuParser_T25"},{"id":"EnjuParser_R25","pred":"arg1Of","subj":"EnjuParser_T31","obj":"EnjuParser_T26"},{"id":"EnjuParser_R26","pred":"arg1Of","subj":"EnjuParser_T29","obj":"EnjuParser_T27"},{"id":"EnjuParser_R27","pred":"arg1Of","subj":"EnjuParser_T29","obj":"EnjuParser_T28"},{"id":"EnjuParser_R28","pred":"arg1Of","subj":"EnjuParser_T31","obj":"EnjuParser_T29"},{"id":"EnjuParser_R29","pred":"arg1Of","subj":"EnjuParser_T31","obj":"EnjuParser_T30"},{"id":"EnjuParser_R30","pred":"arg1Of","subj":"EnjuParser_T23","obj":"EnjuParser_T32"},{"id":"EnjuParser_R31","pred":"arg2Of","subj":"EnjuParser_T36","obj":"EnjuParser_T32"},{"id":"EnjuParser_R32","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T34"},{"id":"EnjuParser_R33","pred":"arg2Of","subj":"EnjuParser_T36","obj":"EnjuParser_T34"},{"id":"EnjuParser_R34","pred":"arg1Of","subj":"EnjuParser_T36","obj":"EnjuParser_T35"},{"id":"EnjuParser_R35","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T36"},{"id":"EnjuParser_R36","pred":"arg1Of","subj":"EnjuParser_T36","obj":"EnjuParser_T37"},{"id":"EnjuParser_R37","pred":"arg2Of","subj":"EnjuParser_T39","obj":"EnjuParser_T37"},{"id":"EnjuParser_R38","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T38"},{"id":"EnjuParser_R39","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T40"},{"id":"EnjuParser_R40","pred":"arg2Of","subj":"EnjuParser_T42","obj":"EnjuParser_T40"},{"id":"EnjuParser_R41","pred":"arg1Of","subj":"EnjuParser_T42","obj":"EnjuParser_T41"},{"id":"EnjuParser_R42","pred":"arg1Of","subj":"EnjuParser_T42","obj":"EnjuParser_T43"},{"id":"EnjuParser_R43","pred":"arg2Of","subj":"EnjuParser_T48","obj":"EnjuParser_T43"},{"id":"EnjuParser_R44","pred":"arg1Of","subj":"EnjuParser_T45","obj":"EnjuParser_T44"},{"id":"EnjuParser_R45","pred":"arg1Of","subj":"EnjuParser_T48","obj":"EnjuParser_T45"},{"id":"EnjuParser_R46","pred":"arg1Of","subj":"EnjuParser_T45","obj":"EnjuParser_T46"},{"id":"EnjuParser_R47","pred":"arg2Of","subj":"EnjuParser_T47","obj":"EnjuParser_T46"},{"id":"EnjuParser_R48","pred":"arg1Of","subj":"EnjuParser_T48","obj":"EnjuParser_T47"},{"id":"EnjuParser_R49","pred":"arg1Of","subj":"EnjuParser_T51","obj":"EnjuParser_T50"},{"id":"EnjuParser_R50","pred":"arg1Of","subj":"EnjuParser_T51","obj":"EnjuParser_T52"},{"id":"EnjuParser_R51","pred":"arg2Of","subj":"EnjuParser_T53","obj":"EnjuParser_T52"},{"id":"EnjuParser_R52","pred":"arg2Of","subj":"EnjuParser_T51","obj":"EnjuParser_T53"},{"id":"EnjuParser_R53","pred":"arg3Of","subj":"EnjuParser_T57","obj":"EnjuParser_T53"},{"id":"EnjuParser_R54","pred":"arg1Of","subj":"EnjuParser_T53","obj":"EnjuParser_T54"},{"id":"EnjuParser_R55","pred":"arg1Of","subj":"EnjuParser_T53","obj":"EnjuParser_T55"},{"id":"EnjuParser_R56","pred":"arg1Of","subj":"EnjuParser_T57","obj":"EnjuParser_T56"},{"id":"EnjuParser_R57","pred":"arg1Of","subj":"EnjuParser_T51","obj":"EnjuParser_T57"},{"id":"EnjuParser_R58","pred":"arg2Of","subj":"EnjuParser_T60","obj":"EnjuParser_T57"},{"id":"EnjuParser_R59","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T58"},{"id":"EnjuParser_R60","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T59"},{"id":"EnjuParser_R61","pred":"arg1Of","subj":"EnjuParser_T60","obj":"EnjuParser_T61"},{"id":"EnjuParser_R62","pred":"arg2Of","subj":"EnjuParser_T63","obj":"EnjuParser_T61"},{"id":"EnjuParser_R63","pred":"arg1Of","subj":"EnjuParser_T63","obj":"EnjuParser_T62"},{"id":"EnjuParser_R64","pred":"arg1Of","subj":"EnjuParser_T57","obj":"EnjuParser_T64"},{"id":"EnjuParser_R65","pred":"arg2Of","subj":"EnjuParser_T66","obj":"EnjuParser_T64"},{"id":"EnjuParser_R66","pred":"arg1Of","subj":"EnjuParser_T65","obj":"EnjuParser_T66"},{"id":"EnjuParser_R67","pred":"arg2Of","subj":"EnjuParser_T68","obj":"EnjuParser_T66"},{"id":"EnjuParser_R68","pred":"arg1Of","subj":"EnjuParser_T68","obj":"EnjuParser_T67"},{"id":"EnjuParser_R69","pred":"arg1Of","subj":"EnjuParser_T71","obj":"EnjuParser_T70"},{"id":"EnjuParser_R70","pred":"arg1Of","subj":"EnjuParser_T69","obj":"EnjuParser_T71"},{"id":"EnjuParser_R71","pred":"arg2Of","subj":"EnjuParser_T73","obj":"EnjuParser_T71"},{"id":"EnjuParser_R72","pred":"arg1Of","subj":"EnjuParser_T73","obj":"EnjuParser_T72"},{"id":"EnjuParser_R73","pred":"arg1Of","subj":"EnjuParser_T73","obj":"EnjuParser_T74"},{"id":"EnjuParser_R74","pred":"arg2Of","subj":"EnjuParser_T77","obj":"EnjuParser_T74"},{"id":"EnjuParser_R75","pred":"arg1Of","subj":"EnjuParser_T77","obj":"EnjuParser_T75"},{"id":"EnjuParser_R76","pred":"arg2Of","subj":"EnjuParser_T77","obj":"EnjuParser_T76"},{"id":"EnjuParser_R77","pred":"arg1Of","subj":"EnjuParser_T77","obj":"EnjuParser_T78"},{"id":"EnjuParser_R78","pred":"arg2Of","subj":"EnjuParser_T82","obj":"EnjuParser_T78"},{"id":"EnjuParser_R79","pred":"arg1Of","subj":"EnjuParser_T80","obj":"EnjuParser_T79"},{"id":"EnjuParser_R80","pred":"arg1Of","subj":"EnjuParser_T82","obj":"EnjuParser_T80"},{"id":"EnjuParser_R81","pred":"arg1Of","subj":"EnjuParser_T82","obj":"EnjuParser_T81"},{"id":"EnjuParser_R82","pred":"arg1Of","subj":"EnjuParser_T73","obj":"EnjuParser_T83"},{"id":"EnjuParser_R83","pred":"arg2Of","subj":"EnjuParser_T85","obj":"EnjuParser_T83"},{"id":"EnjuParser_R84","pred":"arg1Of","subj":"EnjuParser_T85","obj":"EnjuParser_T84"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":328,"end":343},"obj":"Disease"},{"id":"T2","span":{"begin":1172,"end":1179},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0015766"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0015766"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T3","span":{"begin":60,"end":65},"obj":"Body_part"},{"id":"T5","span":{"begin":151,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A4","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A5","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A6","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":437,"end":443},"obj":"Glycan"},{"id":"T2","span":{"begin":594,"end":600},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A4","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":328,"end":343},"obj":"Disease"},{"id":"T2","span":{"begin":1172,"end":1179},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0015766"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0015766"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos15-NCBITAXON","denotations":[{"id":"T1","span":{"begin":307,"end":323},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":328,"end":343},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":1149,"end":1152},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"562"},{"id":"A2","pred":"db_id","subj":"T2","obj":"666"},{"id":"A3","pred":"db_id","subj":"T3","obj":"172918"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T2","span":{"begin":60,"end":65},"obj":"Body_part"},{"id":"T3","span":{"begin":151,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos15-MAT","denotations":[{"id":"T1","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T3","span":{"begin":60,"end":65},"obj":"Body_part"},{"id":"T5","span":{"begin":151,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A4","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"A5","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A6","pred":"mat_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":151,"end":344},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":345,"end":954},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":955,"end":1068},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":1069,"end":1180},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"T2","span":{"begin":151,"end":344},"obj":"Sentence"},{"id":"T3","span":{"begin":345,"end":954},"obj":"Sentence"},{"id":"T4","span":{"begin":955,"end":1068},"obj":"Sentence"},{"id":"T5","span":{"begin":1069,"end":1180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"T2","span":{"begin":151,"end":344},"obj":"Sentence"},{"id":"T3","span":{"begin":345,"end":954},"obj":"Sentence"},{"id":"T4","span":{"begin":955,"end":1068},"obj":"Sentence"},{"id":"T5","span":{"begin":1069,"end":1180},"obj":"Sentence"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":437,"end":443},"obj":"Glycan"},{"id":"T2","span":{"begin":594,"end":600},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A3","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A4","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":307,"end":323},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":328,"end":343},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":1149,"end":1152},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"562"},{"id":"A2","pred":"db_id","subj":"T2","obj":"666"},{"id":"A3","pred":"db_id","subj":"T3","obj":"172918"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T2","span":{"begin":60,"end":65},"obj":"Body_part"},{"id":"T3","span":{"begin":151,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.\nBlood group oligosaccharides are one of the most clinically important antigen families and they may also act as secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. Herein we report the synthesis of spacered (sp = CH2CH2CH2NH2) glycosides of A antigen {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, B antigen{α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-}, LewisX{α-D-Gal-(l→4)-[α-L-Fuc-(l→3)]-β-D-GlcNAc-}, A type-II {α-D-GalNAc-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, B type-II {α-D-Gal-(l→3)-[α-L-Fuc-(l→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-}, H type-II{α-L-Fuc-(l→2)-β-D-Gal-(1→4)-β-D-GlcNAc-}, xenoantigen {α-D-Gal-(l→3)-β-D-Gal-(1→4)-[α-L-Fuc-(l→2)]-β-D-GlcNAc-} and Linear B Type II {α-D-Gal-(l→3)-β-D-Gal-(1→4)-β-D-GlcNAc-} useful for a range of biochemical investigations. This linker was chosen so as to facilitate the future conjugation of the antigens to proteins or other molecules. We also measured the affinities of some synthesized oligosaccharides against El Tor CTB strain from V. cholera."}